These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11034064)

  • 1. MYB oncogene amplification in hereditary BRCA1 breast cancer.
    Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
    Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
    Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
    Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
    Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
    Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
    Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
    Staff S; Isola JJ; Johannsson O; Borg A; Tanner MM
    Br J Cancer; 2001 Oct; 85(8):1201-5. PubMed ID: 11710835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
    Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
    Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
    Sinclair CS; Adem C; Naderi A; Soderberg CL; Johnson M; Wu K; Wadum L; Couch VL; Sellers TA; Schaid D; Slezak J; Fredericksen Z; Ingle JN; Hartmann L; Jenkins RB; Couch FJ
    Cancer Res; 2002 Jul; 62(13):3587-91. PubMed ID: 12097257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
    van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
    Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of DNA amplification on gene expression patterns in breast cancer.
    Hyman E; Kauraniemi P; Hautaniemi S; Wolf M; Mousses S; Rozenblum E; Ringnér M; Sauter G; Monni O; Elkahloun A; Kallioniemi OP; Kallioniemi A
    Cancer Res; 2002 Nov; 62(21):6240-5. PubMed ID: 12414653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
    Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
    Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.
    Bärlund M; Monni O; Kononen J; Cornelison R; Torhorst J; Sauter G; Kallioniemi OLLI-P ; Kallioniemi A
    Cancer Res; 2000 Oct; 60(19):5340-4. PubMed ID: 11034067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
    Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
    Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F; Theillet C
    Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.